132 results on '"Higgins, Joseph"'
Search Results
2. A Federal Panacea?
3. VLDL receptor gene therapy for reducing atherogenic lipoproteins
4. P77: Blood screening for in-vitro mechanical hemolysis testing
5. P80: Techniques for Improving Particle Image Velocimetry Evaluation of a Micro Axial Rotary Blood Pump
6. A Multi-Site Assessment of Anesthetic Overdose, Hypothermic Shock, and Electrical Stunning as Methods of Euthanasia for Zebrafish (Danio rerio) Embryos and Larvae
7. Screening of Anaesthetics in Adult Zebrafish (Danio rerio) for the Induction of Euthanasia by Overdose
8. Translation of AMT-130 Preclinical Data to Inform the Design of the First FDA-approved Human AAV Gene Therapy Clinical Trial in Adults with Early Manifest Huntington’s Disease (4531)
9. Orbital atherectomy for treating calcified iliac artery disease to enable large bore device delivery: A case series report
10. tau Genetics in Frontotemporal Lobe Dementia, Progressive Supranuclear Palsy, and Corticobasal Degeneration
11. Dementia assessment and management in primary care settings: a survey of current provider practices in the United States
12. Impact of a Nutrition-Focused Quality Improvement Intervention on Hospital Length of Stay
13. MRI Volumetric Analysis of 20 Early Manifest Huntington Disease Patients to Determine the Safety of Delivering Gene Therapy to the Striatum (P1.8-048)
14. The Biodistribution and Tolerability of rAAV5-miHTT after Bilateral Intra-striatal Delivery to Non-human Primates (S16.006)
15. Giving Flesh to Culture: An Enactivist Interpretation of Haslanger
16. History and Original Thoughts on the Control Theoretic Approach
17. Frequency of frontotemporal dementia gene variants in C9ORF72, MAPT, and GRN in academic versus commercial laboratory cohorts
18. Analysis of 234 Epilepsy Genes for Sequence and Copy Number Variants Using Next Generation Sequencing (P2.288)
19. The Frequency of LRP4 Autoantibodies in Serum Specimens Sent to a Clinical Laboratory for Myasthenia Gravis Testing (P6.429)
20. Development and Validation of Immunoassays for Paraneoplastic Neurological Disorders using a Parallel Nanoscale Microfluidic Analysis System (P6.147)
21. Rescue of Learning and Memory Deficits in the Human Nonsyndromic Intellectual Disability Cereblon Knock-Out Mouse Model by Targeting the AMP-Activated Protein Kinase–mTORC1 Translational Pathway
22. The Brain Health Assessment for Detecting and Diagnosing Neurocognitive Disorders
23. Analysis of the Repeat Size Distribution of over 82,000 Alleles in the Spinocerebellar Ataxias (P3.005)
24. LRP4 Autoimmune Reactivity in a Diverse Double-Seronegative Myasthenia Gravis Patient Population (P1.125)
25. Clinical Testing for Titin and Ryanodine Receptor Autoantibodies in Myasthenia Gravis Patients (P1.123)
26. Borderline CNBP CCTG Expansions in Myotonic Dystrophy Type 2 in over 16,000 Specimens Analyzed in a Clinical Laboratory (P3.118)
27. US hereditary ataxia mutation frequencies compared to EFNS molecular testing guidelines
28. P1-331: Cerebrospinal Fluid Beta-Amyloid 40 and 42 Quantitation Using a Novel Stabilization Technique
29. What is the Current Value Equation for Dementia Diagnosis and Management: Variation in Costs Across Practice Types (S1.007)
30. Frequency of FTLD Mutations in a Commercial Laboratory Versus a Specialty Clinic (P4.036)
31. The Frequency of Damaging Genetic Variants in a Cohort of Over 1500 Patients with Early Onset Familial Alzheimer’s Disease (P5.163)
32. Development of a Diagnostic Decision Tree for Rapidly Progressive Dementia (P5.182)
33. Analysis of 141 Epilepsy Related Genes Using Next Generation Sequencing in 390 Patients (P5.154)
34. Development of an Expert Consensus Approach to Screening, Assessment, and Diagnosis of Patients at Risk for Neurodegenerative Disease (S1.006)
35. Analytical Performance of a Genome-Phenome Analyzer for Use in a Clinical Laboratory (P5.133)
36. Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD
37. A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders
38. Variants in the COL6A1 , COL6A2 , and COL6A3 Genes in Collagen VI-related Congenital Muscular Dystrophy (P2.042)
39. Frequencies of Mutations in 20 Genes Associated with Hereditary Ataxia: Experience from a US Clinical Laboratory (P2.135)
40. The Frequency of Serum Neural Autoantibodies in Suspected Autoimmune Epilepsy (P6.284)
41. Molecular Combing compared to Southern Blot in Measuring D4Z4 Contractions in FSHD (P2.027)
42. MuSK Autoantibodies in Myasthenia Gravis: Experience with >28,000 Specimens Tested in a Clinical Laboratory (P3.169)
43. A brief review of recent Charcot-Marie-Tooth research and priorities
44. Control of Ethanol Oxidation and Its Interaction with Other Metabolic Systems
45. Effect of Acute and Chronic Administration of Ethanol on the Redox States of Brain and Liver
46. CONTRIBUTORS
47. THE CONTROL THEORETIC APPROACH TO THE ANALYSIS OF GLYCOLYTIC OSCILLATORS
48. DYNAMICS AND CONTROL IN CELLULAR REACTIONS++This work was supported by grants from the Public Health Service (GM 12202) and the Office of Naval Research (N, ONR-551 (15).
49. The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathy
50. Zygosity Detection by Next Generation Sequencing in a Clinical Laboratory (P1.329)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.